author-photo

Kai Hübel

University of Cologne

96

Papers

2179

Citations

Citation Trend

Filter By

Papers (96) Sort By

JournalConferenceOthers

The Addition of Rituximab to Cyclophosphamide, Doxorubicine, Vincristine and Prednisone (CHOP) Prolongs Overall Survival in Previously Untreated Mantle Cell Lymphoma: A Long Term Pooled Trials Analysis

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Long-term survival of patients with mantle cell lymphoma after autologous haematopoietic stem-cell transplantation in first remission: a post-hoc analysis of an open-label, multicentre, randomised, phase 3 trial

2021 The Lancet Haematology
Show All
- Source
- Cite
- Save
Citations (1)
IBCL-131: inMIND: A Phase 3 Study of Tafasitamab + Lenalidomide Add-On to Rituximab vs Placebo + Lenalidomide Add-On to Rituximab for Relapsed/Refractory (R/R) Follicular Lymphoma (FL) or Marginal Zone Lymphoma (MZL)

2021 Clinical Lymphoma, Myeloma & Leukemia
Show All
- Source
- Cite
- Save
Citations (0)
Obinutuzumab Short Duration Infusion Is Preferred By Healthcare Providers and Has Minimal Impact on Patient-Reported Symptoms Among Patients with Untreated, Advanced Follicular Lymphoma

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
A phase 3 study to evaluate the efficacy and safety of tafasitamab plus lenalidomide and rituximab versus placebo plus lenalidomide and rituximab in patients with relapsed/refractory (R/R) follicular lymphoma (FL) or marginal zone lymphoma (MZL).

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Obinutuzumab short-duration infusion (SDI) in previously untreated advanced follicular lymphoma: Results from the end of induction analysis of the phase IV GAZELLE study.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Correction to: The Changing Landscape of Lymphoma Associated with HIV Infection.

2021 Current Oncology Reports
- Kai Hübel
Show All
- Source
- Cite
- Save
Citations (0)
Controversies in the Treatment of Follicular Lymphoma

2020
Show All
- Source
- Cite
- Save
Citations (4)
Final Results of a Phase I/II Trial of the Combination Bendamustine and Rituximab With Temsirolimus (BeRT) in Relapsed Mantle Cell Lymphoma and Follicular Lymphoma.

2020
Show All
- Source
- Cite
- Save
Citations (2)
Biosimilars in oncology: Effects on economy and therapeutic innovations.

2020 European Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (5)

© Copyright 2015-2020 Acemap, Inc. Shanghai Jiao Tong University.

沪ICP备18028330号